About PMC Public Policy

PMC seeks to create a friendlier environment for the advancement of personalized medicine. The coalition focuses on regulation, reimbursement and educating decision makers about personalized medicine.  Based on the diversity of its membership, PMC has established a convincing voice shaping policy about and increasing investment in personalized medicine.  The organization:

• Provides opinion leadership with respect to the evolving discussion of public policy issues that affect personalized medicine;
• Helps educate public, policymakers and government officials about the public and personal health benefits of personalized medicine;
• Serves as a forum for identifying and informing others of those public policies that may impede the ability to deliver the promise of personalized medicine;
• Creates a structure for achieving consensus positions on crucial public policy issues and supporting changes needed to further the public interest in personalized medicine.

Public Policy Committee

The Public Policy Committee governs, under a set of rules previously established by the PMC Board, the adoption of all of the organization's public policy positions, and oversees the strategies by which they are communicated to target audiences, including all branches of the federal government as well as other non-governmental agencies.  The Public Policy Committee Chair is J. Brian Munroe, Endo Pharmaceuticals.